Johnson & Johnson recalls a lot of Imodium

Johnson & Johnson's ($JNJ) McNeil Consumer Healthcare, which has gotten accustomed to recalling products in large quantities, is retrieving a lot of Imodium--nearly 54,000 packages. There is no health threat, just a hole in some packages that, because of exposure, might reduce the diarrhea drug's effectiveness, The Wall Street Journal health blog reports. This is an old hat for the consumer health unit, which since December has had to recall over 12 million products, from children's Tylenol for a stopper problem to Motrin tablets with a dissolution issue. It is a reminder that new CEO Alex Gorsky has got to get manufacturing problems at the company under control or risk his own standing, particularly given that predecessor Bill Weldon was probably asked to retire early in the face of the constant march of recalls. Story | More